Literature DB >> 180051

Hormonal modulation of cyclic adenosine 3',5'-monophosphate-dependent protein kinase activity in rat renal cortex. Specificity of enzyme translocation.

F R DeRubertis, P A Craven.   

Abstract

Many of the intracellular actions of cyclic adenosine 3',5'-monophosphate are expressed through phosphorylation reactions mediated by cAMP-dependent protein kinases, but little is known about hormonal control of endogenous protein kinase activity (PK) in kidney. In the present study, we examined the effects of parathyroid hormone, glucagon, and isoproterenol on cAMP and PK in slices of rat renal cortex. In the presence of 0.5 mM 1-methyl, 3-isobutyl xanthine, all three hormones activated PK in slices, as reflected by an increase in the ratio of enzyme activity assayable in homogenates of the slices without addition of cAMP to the kinase reaction mixture (cAMP-independent activity) over total enzyme activity (+2 uM cAMP in the reaction mixture). When enzyme activity was assayed in whole homogenates prepared from slices, the increase in the enzyme activity ratio (- cAMP/+cAMP) which followed hormonal stimulation was due entirely to an increase in cAMP-independent activity, with no change in total activity. In general, a good correlation existed between the alterations in tissue cAMP levels mediated by the hormones and/or 1-methyl, 3-isobutyl xanthine and concomitant alterations in PK. All three hormones increased PK activity ratios to near unity, suggesting complete enzyme activation. However, the concentrations of parathyroid hormone and glucagon which produced maximal activation of PK were much lower than those required for maximal cAMP responses. Studies with charcoal indicated that these hormonal actions on PK reflected intracellular events rather than representing activation of the enzyme during tissue homogenization, due to release of sequestered cAMP. Thus, homogenization of tissue in charcoal prevented activation of PK by subsequent addition of exogenous cAMP, but did not lower enzyme activity ratios in homogenates of hormone-stimulated cortical slices. When PK was determined in the 20,000 g supernatant fraction of renal cortical slices incubated with the hormones, enzyme activity ratios also increased, but total enzyme activity declined. Lost activity was recovered by extraction of particulate fractions with 500 mM KCl or NaCl, results which implied particulate binding of activated PK. Activated soluble PK from renal cortex was bound equally well by intact, heat- and trypsin-treated renal cortical pellets and by intact and heated hepatic pellets. Accordingly, the apparent translocation of enzyme in hormone stimulated cortex does not necessarily represent binding of the activated PK to specific acceptor sites in the particulate cell fractions or constitute a physiologic hormonal action. Activation of renal cortical PK by increasing concentrations of salts suggests that the enzyme in this tissue resembles the predominant type found in heart.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180051      PMCID: PMC436803          DOI: 10.1172/JCI108414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  On the question of translocation of heart cAMP-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Evidence for persistent binding of biologically active thyrotropin to thyroid in vitro.

Authors:  F R DeRubertis; R Chayoth; U Zor; J B Field
Journal:  Endocrinology       Date:  1975-06       Impact factor: 4.736

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Properties of soluble and bound protein kinases isolated from swine kidney.

Authors:  H Abou-Issa; N Kratowich; J Mendicino
Journal:  Eur J Biochem       Date:  1974-03-01

5.  In vivo regulation of hepatic protein kinase by adenosine 3',5'-monophosphate mediated glucagon stimulation.

Authors:  O Sudilovsky
Journal:  Biochem Biophys Res Commun       Date:  1974-05-07       Impact factor: 3.575

6.  Assay of cyclic AMP-dependent protein kinases.

Authors:  J D Corbin; E M Reimann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Nuclear protein kinase activity in glucagon-stimulated perfused rat livers.

Authors:  W K Palmer; M Castagna; D A Walsh
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

8.  Evidence for a separate adenylate cyclase system responsive to beta-adrenergic stimulation in the renal cortex of the rat.

Authors:  N H Bell
Journal:  Acta Endocrinol (Copenh)       Date:  1974-11

9.  Direct effects of glucagon on renal hemodynamics and excretion of inorganic ions.

Authors:  T N Pullman; A R Lavender; I Aho
Journal:  Metabolism       Date:  1967-04       Impact factor: 8.694

10.  Depression of proximal tubular sodium reabsorption in the dog in response to renal beta adrenergic stimulation by isoproterenol.

Authors:  J R Gill; A G Casper
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  3 in total

1.  Modulation of cyclic AMP-dependent protein kinase by vasopressin and calcitonin in cultured porcine renal LLC-PK1 cells.

Authors:  D A Ausiello; D H Hall; J M Dayer
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

2.  Effects of osmolality and oxygen availability on soluble cyclic AMP-dependent protein kinase activity of rat renal inner medulla.

Authors:  F R DeRubertis; P A Craven
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

3.  Calcium-dependent action of osmolality on adenosine 3',5'-monophosphate accumulation in rat renal inner medulla: evidence for a relationship to calcium-responsive arachidonate release and prostaglandin synthesis.

Authors:  P A Craven; R Briggs; F R DeRubertis
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.